MoneyWorks4Me

Clarification sought from Sun Pharmaceutical Industries

07 Sep 2018 Evaluate

The Exchange has sought clarification from Sun Pharmaceutical Industries on September 07, 2018 with reference to news appeared on: www.moneycontrol.com dated September 07, 2018 quoting ‘Sun Pharma falls 5% on report of co getting 6 observations by US FDA for Halol unit’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1773.85
Dr. Reddys Labs. 1196.40
Cipla 1332.20
Lupin 2006.10
Zydus Lifesciences 1150.65
View more..